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Purpose: To analyze human transforming growth factor b-induced (TGFBI) gene mutations in Chinese patients with
corneal dystrophies (CDs).
Methods: Twenty-one families with corneal dystrophies were subjected to phenotypic and genotypic characterization.
The corneal phenotypes of patients were documented by slit lamp photography. Mutation screening of the coding regions
of TGFBI was performed by direct sequencing. An additional 43 families and 3 sporadic patients with TGFBI dystrophies
from China reported in the literature were reviewed.
Results: Five mutations of TGFBI were identified in 21 families with CDs, including one novel small deletion mutation,
c.△1838–1849 (p.Δ613–616VAEP), responsible for one variant lattice CD (LCD) family and 4 known mutations, R555W
mutation for 10 granular cornea dystrophy type I (GCD1) families, R124H for 5 GCD type II (GCD2), R124C for 4 LCD1,
and H626R for one variant LCD. In a cohort of Chinese patients (n=355) with TGFBI dystrophies from 64 families and
3 sporadic cases, 19 distinct mutations were found in several different CD subtypes. The 3 most common phenotypes
were ranked as follows: GCD1, GCD2, and LCD1. Mutation hot spots at R124 and R555 occurred in >80% of these
families.
Conclusions: Our findings extend the mutational spectrum of TFGBI, and this is also the first extensively delineated
TGFBI mutation profile associated with the various corneal dystrophies in the Chinese population.
Corneal  dystrophies  (CDs)  are  characterized  by  the
occurrence of bilateral progressive opacities of the cornea that
often arise from the deposition of insoluble material in the
corneal stroma and lead to visual impairment. Since 1997,
multiple phenotypes have been identified that are related to
allelic mutations of the human transforming growth factor b-
induced  (TGFBI)  gene  (OMIM  601692)  on  human
chromosome 5q31 [1]. This gene, originally named beta-ig-
h3 (BIGH3), comprises 17 exons coding for a unique protein
of 683-amino acids, which is produced by both mesenchymal
and epithelial cells and denoted as keratoepithelin [1]. At
present, more than 50 distinct disease-causing mutations have
been identified in TFGBI that are associated with different
corneal  dystrophies,  including  granular  cornea  dystrophy
(GCD) type I (GCD1; OMIM 121900), GCD type II (GCD2;
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OMIM  607541),  lattice  corneal  dystrophy  type  I(LCD1;
OMIM  122200),  variant  LCD,  Thiel-Behnke  corneal
dystrophy  (CDTB;  OMIM  602082),  Reis-Buckler  corneal
dystrophy (CDRB; OMIM 608470), and epithelial basement
membrane corneal dystrophy (EBMD; OMIM 121820). In the
present study, we designated all of the cornea dystrophies
associated with TGFBI mutations as TGFBI dystrophies.
Of these mutations, two mutational hot spots have been
identified corresponding to R124 and R555 of the TGFBI
protein as being the most frequent sites of mutation in various
populations  [2-7].  Despite  TGFBI  dystrophies  represent  a
clinically  heterogeneous  group  of  disorders,  a  strong
correlation between specific mutations at these two positions
and  the  observed  phenotypes  has  been  observed:  GCD1/
R555W, CDTB/R555Q, LCD1/R124C, GCD2/R124H, and
CDRB/R124L. These above CDs were also classified as the
classic form of TGFBI dystrophies [8].
The  TGFBI  mutation  spectrum  and  their  clinical
consequences have been investigated in patients with CDs in
different ethnic populations [2-7]. However, the spectrum of
TGFBI mutations and the correlation between genotype and
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1186phenotype in the Chinese population has not been studied
extensively. In this study, we report our findings on 21 new
CD families with TGFBI mutations, and an additional 43
families and 3 sporadic patients with TGFBI dystrophies in a
Chinese population collected from the literature [9-31], and
delineate extensively the TGFBI mutation profile associated
with the various corneal dystrophies in China.
METHODS
Patients and subjects: As part of a genetic screening program
for genetic eye disorders, we collected materials from 26
families diagnosed with corneal dystrophies from China. A
slit-lamp  examination  was  performed  for  all  participating
individuals to determine if they were affected or unaffected
with  corneal  dystrophies  and  to  determine  the  disease
phenotype. Of these families, 21 were further classified into
3  diagnostic  categories:  GCD1  in  10  families,  LCD  in  6
families, and GCD2 in 5 families. The pedigrees of these 21
families are shown in Figure 1, and the slit-lamp photographs
of the representative patients with CDs are shown in Figure 2.
After  informed  consent  conforming  to  the  tenets  of  the
Declaration of Helsinki and following the guidance of sample
collection  of  National  Infrastructure  Program  of  Chinese
Genetic Resources (NICGR), 112 blood samples (58 samples
from patients and 54 from normal members of families) from
the 21 families and other 50 samples from ethnically matched
control individuals were obtained before the study.
Genetic analysis: Total genomic DNA was extracted from
whole blood using the Wizard Genomic DNA Purification Kit
(Promega, Beijing, China) according to the manufacturer’s
instructions. Amplification of the coding regions of TGFBI
from  genomic  DNA  was  performed  with  the  primers  as
described previously [1,2,22]. The sequences of the primers
are listed in Table 1. Each PCR reaction was carried out in a
50 µl reaction mixture containing 100-200 ng of genomic
DNA,  0.25  µl  of  TaKaRa  Ex  TaqTM  (5U/µl;  TaKaRa
Biotechnology Co., Ltd., Dalian, China), 4.0 µl of dNTPs (2.5
mM each), 1.0 µl of each primer (10 pmol), 5 µl of 10× Ex
Taq Buffer (Mg2+ plus). PCR conditions were as follows: 94
°C for 3 min; 30 cycles of 94 °C for 30 s, 52 °C or 55 °C or
58 °C for 30 s, 72 °C for 1 min; and further extension step at
72 °C for 5 min. PCR products were purified and sequenced
on an ABI 3730XL Automated Sequencer (PE Biosystems,
Foster City, CA), using the same PCR forward primers.
Publications selection: To evaluate the incidence of TFGBI
mutations in Chinese patients with TGFBI dystrophies, we
also reviewed published articles obtained by an electronic
search  on  PubMed/MEDLINE,  VIP  Information,  CNKI,
WANGFANG, data and Google using the keywords “corneal
dystrophy” and “TGFBI” or “BIGH3.” Articles were limited
to full papers in the English or Chinese language literature,
and the search ended in February, 2010. When the same author
reported  results  obtained  on  a  complete  or  partial  similar
patient  population  in  several  publications,  only  the  most
recent or the most complete report was included in the analysis
to avoid overlap. According to these criteria, 23 eligible trials
published between 2002 and 2010 were selected [9-31]. The
articles  reported  mutations  of  the  TGFBI/BIGH3  gene
associated with corneal dystrophies in the Chinese population.
All of these TGFBI dystrophies were reclassified as classic or
variant form according to Aldave and Sonmez’s [8] criterion.
RESULTS
Mutational  analysis:  We  screened  the  coding  regions  of
TGFBI using PCR-based ampliﬁcation followed by direct
sequencing. Mutations were identified in all patients from the
21  unrelated  Chinese  families  (Figure  1).  Five  distinct
mutations  of  TGFBI  were  identified,  including  one  novel
small deletion mutation, c.Δ1838–1849 (p.Δ613–616VAEP),
in exon 14 responsible for the HCD-022 family with variant
LCD (Figure 1E and Figure 2I). This mutation was found in
the proband and her son, but not in her parents and 50 normal
controls.  The  other  four  known  mutations  were  R555W
mutation for 10 GCD1 families (Figure 1A and Figure 2A-C),
R124H for 5 GCD2 families (Figure 1B and Figure 2D),
R124C for 4 LCD1 families (Figure 1C and Figure 2G) and
H626R for one variant LCD family (Figure 1D and Figure
2H).
Profile  of  TGFBI  dystrophies:  To  delineate  the  TGFBI
mutation  profile  associated  with  the  various  corneal
dystrophies  in  the  Chinese  population,  an  additional  43
families  and  3  sporadic  cases  with  TGFBI  dystrophies
collected  from  the  literature  were  also  included  in  the
investigation. Thus, a total of 355 patients from 64 families
and  3  sporadic  patients  were  included  in  the  statistical
analysis. We reclassified these TGFBI dystrophies as classic
or variant form, with GCD1/R555W, GCD2/R124H, LCD1/
R124C, CDRB/R124L, and CDTB/R555Q as classic forms
and the others as corresponding variants [8].
In this cohort of Chinese patients, 19 distinct TGFBI
mutations were identified in several different CD subtypes
(Table 2). The most common phenotypes were the GCD1
associated with the R555W mutation (26.6%, 17/64 families),
GCD2 with the R124H mutation (26.6%,17/64families), and
LCD1 with the R124C mutation (18.8%,12/64 families). The
mutational hot spots at positions R124 and R555 occurred in
53.1%  (34/64)  and  28.1%  (18/64)  of  the  families,
respectively. Our observation also showed that the phenotypes
correlated  strongly  with  specific  mutations  in  TGFBI,
including  that  between  GCD1  and  R555W,  GCD2  and
R124H, and LCD1 and R124C. The exception is two CDTB
families associated with the R124C mutation [26]. In addition,
more than half (11/19) of these mutations were observed in
Chinese patients with variant LCDs (Table 2).
DISCUSSION
We searched for mutations of TGFBI in 21 unrelated Chinese
families affected with GCDs or LCDs. Five distinct mutations
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1187Figure 1. Pedigrees of 21 Chinese families with corneal dystrophies and sequence chromatograms of their corresponding mutations TGFBI.
GCD 1/R555W mutation (A), GCD2/R124H mutation (B), LCD1/R124C mutation (C), variant LCD/H626R mutation (D), and Variant LCD/
￿613–616VAEP mutation ( E). Squares and circles symbolize males and females, respectively. The open and closed symbols indicate
unaffected and affected individuals, respectively. The proband is marked with an arrow.
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1188of TGFBI were identified in all of the families (Figure 1), and
there  have  been  perfect  correlations  between  GCD1  and
R555W, between GCD2 (ACD) and R124H, and between
LCD1 and R124C. Among of these mutations, one novel 12
bp deletion mutation, c.Δ1838–1849 (p.Δ613–616VAEP), in
exon 14 was found in the HCD-022 family (Figure 1E) with
variant LCD (Figure 2I). Compare with the five small deletion
mutations (1~6 bp deleted) in TGFBI reported previously by
Figure 2. Representative corneal phenotypes as shown by slit lamp examination. The proband of GCD1 family HCD-007 with R555W mutation
had crumb-shaped and round white opacities (A). The proband of GCD1 family HCD-023 with R555W mutation showed confluent gray white
opacities in a fan-like distribution in the central cornea (B) and recurrence corneal deposits after penetrating keratoplasty (C). The proband
of GCD2 family HCD-016 with R124H mutation showed that the corneal opacities resemble rings, disks or snowflakes (D). The patient with
the severe form of corneal dystrophy had confluent round white opacities in a coralloid shape in the superficial stromal layer (E), whereas his
brother had fewer round opacities and thick spicular opacities (F) in a consanguineous marriage Chinese family clinically diagnosed as GCD2.
The proband of LCD1 family HCD-005 with R124C mutation showed numerous fine, branching refractile lattice lines in subepithelial and
stromal layers of the cornea (G). The proband of LCD family HCD-010 with H626R mutation showed recurrent diffuse stromal haze (H).
The proband of LCD family HCD-022 with△613–616VAEP mutation showed thick, stellate lattice lines with intervening opacities and
extending more to the periphery (I).
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1189other  groups  [2,4,9,32,33],  this  mutation  was  the  longest
deletion  mutation  in  TGFBI.  It  was  also  identified  as  a
spontaneous inheritable TGFBI mutation because only the
proband and her affected son carried the mutation, and not her
parents. Spontaneous mutations in this gene are rare, but have
been reported. Tanhehco et al. [34] reported a spontaneous
R124L mutation in TGFBI in 2 patients with CDRB, and Zhao
et  al.  [35]  reported  a  spontaneous  R555Q  mutation  in
TGFBI in two unrelated families with Bowman's layer corneal
dystrophies (CDTB and CDRB). Our finding not only extends
the mutational spectrum of TFGBI, but also has historic value
as a possible explanation for the presence of this autosomal
dominant disorder in the population.
Through  extensive  investigation  of  the  clinical  and
genetic  findings  in  TGFBI  dystrophies  in  the  Chinese
population, we observed that GCD1 in association with the
R555W mutation (17 families) and GCD2 in association with
the R124H mutation (17 families) accounted for more than
half  (53.1%,  34/64)  of  the  families  and  were  the  most
prevalent type of this disease. Our observations also confirm
the presence of mutation hot spots at positions R124 and
R555, which occur in more than 80% (52/64) of the families
with  TGFBI  dystrophies  in  China.  There  were  strong
TABLE 1. SUMMARY OF THE PRIMERS USED FOR THE AMPLIFICATION OF THE 17 EXONS OF THE HUMAN TGFBI GENE.
Exon Primersequnce(5’→3') Annealing
temperature (°C)
Amplicon
length (bp)
1 F: GCGCTCTCACTTCCCTGGAG 52 252
  R: GACTACCTGACCTTCCGCAG    
2 F: GGTGGACGTGCTGATCATCT 58 194
  R: AGCCAGCGTGCATACAGCTT    
3 F: ACCTGTGAGGAACAGTGAAG 58 200
  R: GCCTTTTATGTGGGTACTCC     
4 F: CCCCAGAGGCCATCCCTCCT 58 225
  R: CCGGGCAGACGGAGGTCATC    
5 F: TAAACACAGAGTCTGCAGCC 58 260
  R: TTCATTATGCACCAAGGGCC    
6 F: TGTGTTGACTGCTCATCCTT 58 317
  R: CATTCAGGGGAACCTGCTCT    
7 F: TTCAGGGAGCACTCCATCTT 55 224
  R: ATCTAGCTGCACAAATGAGG    
8 F: CTTGACCTGAGTCTGTTTGG 58 324
  R: GAAGTCGCCCAAAGATCTCT    
9 F: ACTTTTGAACCCACTTTCTC 58 200
  R: CAATCTAACAGGGATGCCTT    
10 F: TCTGGACCTAACCATCACCC 58 206
  R: CAGGAGCATGATTTAGGACC    
11 F: CTCGTGGAAGTATAACCAGT 58 223
  R: TGGGCAGAAGCTCCACCCGG    
12 F: CATTCCAGTGGCCTGGACTCTACTATC 58 318
  R: GGGGCCCTGAGGGATCACTACTT    
13 F: GGGATTAACTCTATCTCCTT 58 249
  R: TGTGTATAATTCCATCCTGG    
14 F: CTGTTCAGTAAACACTTGCT 58 262
  R: CTCTCCACCAACTGCCACAT    
15 F: CACTCTGGTCAAACCTGCCT 58 147
  R: AGGCTAGGCGCAAACCTAGC    
16 F: CAGTTGCAGGTATAACTTTC 58 120
  R: TAAACAGGTCTGCAATGACT    
17 F: GGGAGATCTGCACCTATTTG 58 113
  R: TGGTGCATTCCTCCTGTAGT    
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1190genotype-phenotype  correlations  between  R555W  and
GCD1, between R124H and GCD2, and between R124C and
LCD1 in our collection of 64 families, which is consistent with
previous reports in patients from other ethnic origins [2-7].
The exception is 2 Chinese typical CDTB families associated
with the R124C mutation [26]. Although these two mutations
have been identified as major causes of LCDs or GCDs in
different ethnic groups [2-7], population-specific variations in
the prevalence of different mutations in TGFBI have been
documented. The classic form of GCD1 with the R555W
mutation  and  LCD1  with  the  R124C  mutation  are  more
common in different ethnic groups in Europe, the United
States, and India [2,4,6,7], but in other populations, such as in
Japan and Korea, GCD1 is found much less frequently than
GCD2 associated with the R124H mutation [3,5], and H626R
may be more frequent than R124C in Vietnamese patients
with LCDs [36].
The second common type of TGFBI dystrophies is the
LCDs, which accounted for more than one third of all of the
families (34.4%, 22/64) in the Chinese population. Of these
LCDs families, the major subtype is the classic form of LCD
(LCD1) associated with the R124C mutation (54.5%,12/22).
The  other  different  forms  of  lattice  dystrophy  were
reclassified  as  variant  LCDs,  which  were  the  most
mutationally  heterogeneous  and  accounted  for  half  of  the
mutations identified. In comparison to these common types,
CDRB and CDTB were rare (about 5% of each subtype) in
the Chinese population.
Most of the TGFBI mutations associated with corneal
dystrophies  are  heterozygous.  However,  homozygous
mutations are also found in some patients with severe form of
TGFBI  dystrophies  [37,38].  Only  two  patients  bearing
homozygous  R124H  mutations  from  a  consanguineous
marriage family with GCD2 have been reported in China
[24].  This  disease  is  also  described  as  a  semidominant
condition in which the heterozygous mutant is less severely
affected than the homozygote. We also found a patient with
severe  form  of  corneal  dystrophy  in  a  consanguineous
marriage  family  clinically  diagnosed  as  GCD2.  He  had
confluent round opacities in a coralloid shape in both of his
eyes (Figure 2E), which is similar in phenotype to the patients
with GCD2 bearing a homozygous R124H mutation reported
previously [38]. His parents and brother had fewer round
opacities and spicular opacities (Figure 2F). Unfortunately,
we could not obtain blood samples for gene examination.
In addition to allelic heterogeneity, TGFBI dystrophies
also exhibited extensive intrafamily and interfamily variations
in  clinical  phenotypes,  even  when  the  same  single  point
mutation in TGFBI is involved. Perhaps the most extreme
example of the phenotypic variability is unaffected carriers
who  had  the  disease-causing  mutations  in  TGFBI.  In  our
collection of 64 Chinese families, 11 these carriers from 4
families  were  reported  [21,23,24].  Of  these  cases,  2
unaffected  relatives  bearing  the  A546D  mutation  from  a
GCD1 family [23] and 2 from 2 LCD1 families carrying the
R124C mutation [21] were too young to rule out inheritance
of these two diseases by clinical examination. However, 7
individuals  carrying  a  heterogeneous  R124H  mutation
showed no clinical manifestations in a reduced penetrance
GCD2 Chinese family, and an age-related factor was excluded
in the contribution to these carriers [24]. All of this clinical
evidence  suggests  that  other  factors  such  as  age,
environmental factors, and modifier genes may influence the
expressivity and the penetrance of this disease, but further
studies are needed for confirmation.
TABLE 2. TGFBI MUTATIONS AND PHENOTYPES OF PATIENTS IN 61 FAMILIES AND 3 SPORADIC CASES FROM CHINESE ORIGIN.
Corneal
phenotype
Mutation Exon Number of
families
Number of patients
(Male/Female)
Reference
GCD1 R555W 12 17 92 (37/65) [10-12,17,18,23,28], This study
  A546D 12 1 10 (6/4) [23]
GCD2 R124H 4 17 65 (32/33) [10-12,17,24,25], This study
  R124H+c.Δ307–308CT 4   1 [9]
LCD1 R124C 4 12 89 (43/46) [15,16,21,25,31], This study
Variant LCD H626R 14 3 14 (7/7) [15,25], This study
  V505D 11 1 10 (4/6) [14]
  T538P 12 1 3 (1/2) [16]
  V625D 14 1 2 (1/1) [20]
  Δ613–616VAEP 14 1 2 (1/1) This study
  I522N 12 1 4 (1/3) [29]
  P501T 11   1 [16]
  R514P+F515L 11 1 5 (4/1) [31]
  A546T 12   1 [30]
  H572R 13 1 3 (2/1) [31]
CDRB R124L 4 3 14 (3/11) [10,13]
  G623D 14 1 7 (3/4) [22,27]
CDTB R555Q 12 1 14 (6/8) [17,19]
  R124C 4 2 18 (9/9) [26]
Total 19   64 355  
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1191In summary, this study reported our findings in 21 new
CD  families  with  TGFBI  mutations,  and  delineated
extensively the TGFBI mutation profile associated with the
various corneal dystrophies in the Chinese population: both
GCD1 associated with the R555W mutation and GCD2 with
the  R124H  mutation  are  the  most  common  forms  of  this
disease.  We  also  confirmed  the  presence  of  mutational
hotspots at positions R124 and R555, and a strong correlation
between these two mutations and their phenotypes.
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